Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-05-01
1991-11-05
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546271, 546118, 546121, 546255, 546256, 546257, 544262, C07D40110, A61K 31415
Patent
active
050632370
ABSTRACT:
Platelet activating factor antagonists of formula (I): ##STR1## wherein R is phenyl or phenyl substituted by one or more substituents selected from nitro, halo, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, aryl(C.sub.1 -C.sub.4)alkoxy, fluoro(C.sub.1 -C.sub.4)alkoxy, C.sub.1 -C.sub.4 alkylthio, C.sub.1 -C.sub.4 alkylsulphonyl, hydroxy, trifluoromethyl and cyano, or is phenyl fused to a dioxole ring;
REFERENCES:
patent: 3971791 (1976-07-01), Meyer
patent: 4285955 (1981-08-01), Wehinger et al.
patent: 4414213 (1983-11-01), Poindexter et al.
patent: 4788205 (1988-11-01), Cooper et al.
patent: 4820842 (1989-04-01), Anderson et al.
Cooper Kelvin
Fray Michael J.
Richardson Kenneth
Steele John
Lumb J. Trevor
McManus James M.
Pfizer Inc.
Richardson Peter C.
Rotman Alan L.
LandOfFree
1,4-dihydro-2-(4-[benzimidazol-l-yl]phenyl)-pyridines as platele does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,4-dihydro-2-(4-[benzimidazol-l-yl]phenyl)-pyridines as platele, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,4-dihydro-2-(4-[benzimidazol-l-yl]phenyl)-pyridines as platele will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-499580